Central bankers weigh up Facebook’s Libra plan
June 25, 2019Futures lower on Iran tensions, trade worries
June 25, 2019AbbVie to buy Botox-maker Allergan in $63 billion deal
at
Drugmaker AbbVie Inc said on Tuesday it would buy Botox-maker Allergan Plc for about $63 billion, grabbing control of by far the biggest name in medical aesthetics to help reduce its reliance on blockbuster arthritis treatment Humira.
Powered by WPeMatico
